Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02133417 · ClinicalTrials.gov registry record
Non-Inferiority Quantitative Transmission Ultrasound Case Collection Study
A clinical trial of Mass Lesion, sponsored by QT Ultrasound.
- Completed
- Registry status
- 287
- Enrollment target
- 2
- Study locations
NCT02133417: Completed study of Mass Lesion, sponsored by QT Ultrasound.
NCT02133417 is a study of Mass Lesion that has completed, run by QT Ultrasound. The registered enrollment target is 287 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02133417, a study of Mass Lesion, has completed, sponsored by QT Ultrasound.
- COMPLETED
- Registry status
- 287 participants
- Enrollment target
- 2
- Study locations
Study Summary
Conduct a case collection study of breast imaging examinations from women with mammographically-detected breast lesions for the purpose of conducting subsequent Reader Studies.
Primary Outcome
This is a prospective Case Collection study for the purpose of conducting subsequent Reader Studies. The primary objective for this prospective case collection study is to provide up to 300 cytology/pathology confirmed cases for subsequent Reader Studies.
Conditions Studied
Interventions
- DEVICE Quantitative Transmission Ultrasound
Study Locations (2)
District of Columbia
- George Washington University Medical Center - Washington D.C.
New York
- Elizabeth Wende Breast Care, LLC - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-01 |
What the finished NCT02133417 record still lists
NCT02133417 is an observational study that tracks outcomes without assigning an intervention. The registered 287 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Mass Lesion appearing as the primary indexed condition, and to 1 intervention - of which Quantitative Transmission Ultrasound is the first listed.
NCT02133417 reports a single indexed study location in District of Columbia, New York.
Frequently Asked Questions
What is clinical trial NCT02133417 about?
NCT02133417 is a clinical study titled "Non-Inferiority Quantitative Transmission Ultrasound Case Collection Study". Conduct a case collection study of breast imaging examinations from women with mammographically-detected breast lesions for the purpose of conducting subsequent Reader Studies.
What is the current status of trial NCT02133417?
This trial is currently completed. The enrollment target is 287 participants. The study started on 2014-07. Estimated completion is 2016-01.
What conditions does trial NCT02133417 study?
This clinical trial studies the following conditions: Mass Lesion.
What interventions are being tested in trial NCT02133417?
The interventions under investigation include: Quantitative Transmission Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT02133417?
This trial is sponsored by QT Ultrasound, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02133417 being conducted?
This trial has 2 study locations across District of Columbia, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mass Lesion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03094429 · 287 participants · Phase 2
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
- NCT06385080 · 287 participants · Phase 1
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- NCT06919224 · 287 participants · NA
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia